Deepcell is a biotechnology company based in Menlo Park, California, pioneering the integration of artificial intelligence (AI) with microfluidics and high-resolution imaging to transform single-cell analysis. Founded in 2017 by Maddison Masaeli, Ph.D., Euan Ashley, M.D., Ph.D., and Mahyar Salek, Ph.D., Deepcell emerged from research at Stanford University with the mission to revolutionize cell biology through AI-driven morphological analysis.
Deepcell
Series B
$100M - $1B